After a heart attack, a new type of treatment, administered directly into the damaged blood vessel, stimulates healing. This could help prevent heart failure due to scarring, the researchers say.
As access to TIL therapy remains limited across Europe, Sheba Medical Center combines 15+ years of experience, in-house manufacturing, and pioneering research to advance melanoma and CAR-T therapies.
Photothermal therapy to selectively destroy cancer cells shows promise as a much less invasive treatment option than surgery or radiation. Now, researchers cleared two major hurdles for the method.
A swallowable "nanocage" may offer a new strategy for treating gastric cancer more precisely while reducing damage to healthy tissue, according to findings from a new preclinical study.
What people believe about a treatment can influence how they respond to it – but how are those beliefs formed? A new review shows how medical practitioners can help their patients improve outcomes.
A pilot study shows that immunotherapy may enable stimulation of egg maturation in women with premature menopause. Three out of ten women gave birth to healthy babies following the treatment.
A study from the University of Calgary shows that removing a single gene makes colon cancer cells a target for immunotherapy — a fundamental breakthrough.
Radiopharmaceutical therapy has already transformed care for neuroendocrine tumors and prostate cancer, but other tumor types still lack targeted treatment options. A new approach could change this.
For patients with knee osteoarthritis, for whom injections no longer provide sufficient relief, but joint replacement is also not an option, a minimally invasive treatment might offer an alternative.
A promising technology enables deep brain stimulation without the need to surgically implant electrodes. This could pave the way for its use in the treatment of neurological and psychiatric disorders.
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options.
Researchers have reported results from a first-in-human trial evaluating a novel cell-based platform for localized delivery of interleukin-2 (IL-2) in patients with advanced ovarian cancer.
A CRISPR-based tool called Cas12a2 can selectively eliminate cancer and virus-infected cells based on their RNA signature – with high precision and no off-target effects.
Researchers are developing nanozymes to improve treatment of aggressive brain tumours. The tiny particles can be activated by near-infrared light and applied directly during surgery.
Now, a new study identified a gene therapy for individuals with cystic fibrosis (CF) caused by a specific mutation and for whom there was no treatment available until now.
Most children with a broken wrist can be treated without surgery, a major trial finds, suggesting that a cast-first approach delivers similar long-term recovery while reducing risks and costs.
A multidisciplinary team of pathologists, oncologists and biologists has discovered a new biomarker to determine whether immunotherapy may work in people with colon and rectal cancer.
A clinical trial has shown that post-thrombotic syndrome — a common and often painful complication after deep vein thrombosis — can be effectively treated with a minimally invasive procedure.
Why do some cancer cells develop treatment resistance? The answer may lie in hidden “storage hubs” inside tumour cells, which create uneven drug exposure across tumours, according to new research.
